OTLK icon

Outlook Therapeutics
OTLK

Overview Fund Activity

20 hedge funds and large institutions have $2.17M invested in Outlook Therapeutics in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-2
Holders Change %
-9.09%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
10
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LA
1
LVW Advisors
New York
$871K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$154K
3
CS
3
Credit Suisse
Switzerland
$65K
4
Northern Trust
4
Northern Trust
Illinois
$96K
5
Squarepoint
5
Squarepoint
New York
$21K

Top Sellers

1
SM
1
Sabby Management
Florida
$0
2
AC
2
Armistice Capital
New York
$0
3
DI
3
DFPG Investments
Utah
$0
4
BRWM
4
B. Riley Wealth Management
Tennessee
$0
5
Barclays
5
Barclays
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$1K -42 Closed
1
2